Dear Readers,
Gene therapy is one of the most exciting developments in modern medicine. By modifying or replacing faulty genes, this approach seeks to treat diseases at their very source. In recent years, it has gained special attention in ophthalmology, as many eye disorders have a strong genetic basis.
The success of Luxturna the first approved gene therapy for an inherited retinal disease—has shown that restoring sight through genetic treatment is possible. Researchers are now exploring similar approaches for conditions like retinitis pigmentosa, Leber congenital amaurosis, and age-related macular degeneration. These efforts open a new horizon of hope for patients who previously had very limited treatment options.
This site news covers the general aspects of gene therapy, its application in eye care, and the key advantages and disadvantages shaping its future. Your feedback will help us improve the newsletter. Please send in your feedback at eyesite@aravind.orgThank You. Have a happy reading. Regards, Library Team |
|
- GENE THERAPY: THE NEXT FRONTIER FOR TREATMENT OF ACQUIRED AND INHERITED OCULAR DISORDERS
This webpage discusses how gene therapy can treat retinal diseases by delivering functional genes to replace defective ones.
- GENE THERAPY FOR AMD
This article highlights how the latest advances in gene therapy are set to revolutionize treatment for age-related macular degeneration (AMD).
- GENE THERAPIES AS A GAME-CHANGER IN OPHTHALMOLOGY
This article focuses on gene therapy, which is rapidly evolving as a groundbreaking approach in ophthalmology.
- THE SAFETY AND EFFICACY OF GENE THERAPY TREATMENT FOR MONOGENIC RETINAL AND OPTIC NERVE DISEASES: A SYSTEMATIC REVIEW
This study aimed to systematically review and summarize gene therapy treatment for monogenic retinal and optic nerve diseases.
- GENE THERAPY & CLINICAL TRIALS TO TREAT VISION LOSS
This webpage contains an overview of gene therapy in ophthalmology, including the first approved treatment (Luxturna®), current clinical trials, types of gene therapy approaches, eligibility criteria, and a list of ongoing studies for vision loss.
- IS GENE THERAPY THE NEXT BIG STEP IN VISION LOSS TREATMENT?
This article focuses on retinal diseases as major causes of vision loss. It highlights the promise of gene therapy in treating these conditions while noting the challenges that remain.
- TACKLING BLINDNESS THROUGH GENE THERAPY
This article focuses on how gene therapy is transforming the treatment of blinding eye diseases, aiming to improve quality of life, extend productive years for patients, and reduce the burden of long-term care.
- NEW TREATMENTS FOR RETINITIS PIGMENTOSA
This article focuses on Luxturna, a gene therapy that treats inherited blindness caused by RPE65 mutation.
- OCULAR GENE THERAPY: THE GOOD, THE BAD, AND THE MAYBE
This artilce explore the potential of gene therapy in treating eye diseases, highlighting its promising successes, current challenges, and the uncertainties that still need to be addressed for future advancements.
- OCULAR CELL AND GENE THERAPY GROUP
This webpage contains details about the ocular, cell, and gene therapy group research activities, projects, and their publications
- GENE THERAPY RESEARCH FOR EYE DISEASE AND VISION LOSS
This article provide the deatils of Gene therapy for eye diseases.
- LUXTURNA
This webpage gives details of Luxturna and how its work and other related information.
|
|
- GENETIC THERAPIES BENEFITS AND RISKS
This NIH article focuses on the benefits and risks of gene therapy.
- CHALLENGES IN GENE THERAPY
This website highlights some of the main challenges in gene therapy, including safety concerns, high costs, delivery methods, and long-term effectiveness.
- TARGETED GENE THERAPY: PROMISES AND CHALLENGES IN DISEASE MANAGEMENT
This article focuses on targeted gene therapy, its therapeutic potential, and the need for further research and technological advances to achieve safe and effective clinical treatments.
- WHAT ARE THE CHALLENGES IN GENE THERAPY DEVELOPMENT?
This webpage explains the main challenges faced in the development of gene therapy, including safety, delivery methods, and long-term effectiveness.
- SEEING THE FUTURE OF GENE THERAPY
This webpage contains the abstract of the Eye and Ear Foundation’s webinar, “Seeing the Future of Gene Therapy,” summarizing current clinical options and emerging therapies.
|
|
You can also refer your friends to register with the innovative resources. Send in your friend's e-mail id to us at eyesite@aravind.org with the subject line Register my friend's id!
Subscribe Sitenews
If you want to unsubscribe from our mailing list and from all our communications please click on the following link:
Unsubscribe Sitenews
Address:
Vision 2020 e-resource team,
Lions Aravind Institute of Community Ophthalmology,
1, Annanagar, Madurai - 625 020,
Tamil Nadu, India,
E-mail:eyesite@aravind.org
Phone: 91-452-2537580
| |
|
GENE THERAPY IN GENERAL
GENE THERAPY AND OCULAR DISEASES
CHALLENGES IN GENE THERAPY
Talk To Us 